Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Hellerup
SEC filing record 1 source field available
Fiscal year end
31 December
Ascendis Pharma A/S has filed 768 SEC EDGAR filings since 01 Aug 2014

SEC filing history

Showing 151-175 of 768 matching filings.

Per page
25
Current page
7
144 File 001-36815

144 filing

Filing date
04 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36815

144 filing

Filing date
04 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36815

144 filing

Filing date
03 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36815

144 filing

Filing date
21 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36815

144 filing

Filing date
20 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36815

144 filing

Filing date
19 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36815

144 filing

Filing date
19 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36815

144 filing

Filing date
18 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88586

SCHEDULE 13G/A filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
12 Feb 2025
Reporting date
12 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
12 Feb 2025
Reporting date
12 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
12 Feb 2025
Reporting date
12 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88586

SCHEDULE 13G/A filing

Filing date
11 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88586

SCHEDULE 13G/A filing

Filing date
10 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
15 Jan 2025
Reporting date
15 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
13 Jan 2025
Reporting date
13 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
13 Jan 2025
Reporting date
13 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
30 Dec 2024
Reporting date
30 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
17 Dec 2024
Reporting date
17 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
12 Dec 2024
Reporting date
12 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36815

6-K

Filing date
11 Dec 2024
Reporting date
11 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36815

144 filing

Filing date
10 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36815

144 filing

Filing date
10 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .